Alvotech ALVO

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $5.37
Market Cap $1.78B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑1.0% YoY
$276.27M
3-Yr CAGR: 123.2%
Net Income ↑162.7% YoY
$136.35M
Net Margin: 49.4%
Free Cash Flow ↓-538.1% YoY
-$5.52M
FCF Yield: -0.31%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 9.2%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ALVO)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2023: Revenue YoY (+96.1%) is identical to Gross Profit YoY (+96.1%). Verify the underlying Revenue and Gross Profit values for FY 2023 and FY 2022.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2020 $66.6M $66.6M $-291.8M $-5.7M
FY 2021 -100.0% $-149.2M +48.9% $28.0M
FY 2022 $24.8M $24.8M $-551.6M -269.7% 0.00% $35.4M $-2.1M
FY 2023 $48.7M +96.1% $48.7M $-651.0M -18.0% 0.00% $57.3M $24.2M +1,234.5%
FY 2024 $273.5M +461.6% $88.2M $-217.6M +66.6% 0.00% $54.9M $1.3M -94.8%
FY 2025 $276.3M +1.0% $40.7M $136.3M +162.7% 0.00% $59.0M $-5.5M -538.1%
$

Valuation

Market Price $5.37
Market Cap $1.78B
Enterprise Value $1.60B
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -0.31%
Dividend Yield 0.00%
Shares Outstanding 330,284,200
%

Profitability & Margins

Gross Margin 14.74%
Operating Margin 28.31%
Net Margin 49.35%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) 9.17%
Asset Turnover 0.19x
Revenue 3-Yr CAGR 123.23%
🛡️

Financial Health & Liquidity

Current Ratio 45.13
Cash Ratio 165.57
Debt / Equity -0.000
Debt / Assets 0.000
Cash & Equivalents $172.36M
Total Debt N/A
Book Value / Share $-0.86
💧

Cash Flow Efficiency

Operating Cash Flow $58.95M
Capital Expenditures (CapEx) $64.47M
Free Cash Flow -$5.52M
OCF / Revenue 21.34%
FCF / Revenue -2.00%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-0.86
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $1.49B
Total Liabilities $1.77B
Stockholders' Equity -$284.49M
Current Assets $46.98M
Current Liabilities $1.04M